Discover outperforming stocks and invest smarter with Top Smart Score Stocks Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener Icon ( (ICLR ...

Fintel reports that on January 7, 2025, RBC Capital initiated coverage of ICON Public Limited (NasdaqGS:ICLR) with a Outperform recommendation. As of December 23, 2024, the average one-year price ...

(RTTNews) - ICON plc (ICLR) announced the appointment ... and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...

Fiduciary Management Inc. (FMI), an independent money management firm, released its “FMI International Equity Strategy ...

Investment analysts at Royal Bank of Canada assumed coverage on shares of ICON Public (NASDAQ:ICLR – Get Free Report) in a note issued to investors on Tuesday, MarketBeat.com reports.

ICLR opened at $213.28 on Thursday. ICON Public has a 1 year low of $183.38 and a 1 year high of $347.72. The stock has a 50-day moving average price of $212.09 and a 200-day moving average price ...

ICON Public Trading Down 0.5 % NASDAQ ICLR opened at $218.22 on Friday. The company has a current ratio of 1.34, a quick ratio of 1.34 and a debt-to-equity ratio of 0.35. ICON Public Limited has a ...

Shares of ICON Public Limited Company (NASDAQ:ICLR) reached a two-month high on Tuesday after RBC Capital Markets launched its coverage with an Outperform recommendation and a $263 target ...

ClearBridge Investments, an investment management company, released its “ClearBridge Large Cap Growth Strategy” fourth ...

VALENCIA, Calif., Dec. 31, 2024 /PRNewswire/ -- Cunard is setting the tempo for music collaborations in 2025 with globally renowned jazz artists Jools Holland OBE and Jamie Cullum* headlining ...

ICON Public (NASDAQ:ICLR – Free Report) had its target price cut by Citigroup from $300.00 to $290.00 in a research report report published on Monday,Benzinga reports.They currently have a buy ...

ICON (NASDAQ:ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research ...